Trials / Unknown
UnknownNCT03771859
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
An Observational Study in Patients Receiving Adjuvant Nivolumab Therapy for Resected Melanoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 152 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study of melanoma participants who are eligible for and who have initiated treatment with adjuvant nivolumab as part of routine clinical practice.
Detailed description
Participants receiving adjuvant nivolumab therapy could be enrolled prospectively and retrospectively.
Conditions
Timeline
- Start date
- 2019-01-16
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
- First posted
- 2018-12-11
- Last updated
- 2021-09-14
Locations
14 sites across 2 countries: Belgium, Luxembourg
Source: ClinicalTrials.gov record NCT03771859. Inclusion in this directory is not an endorsement.